暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
CTVA Corteva
- 54.920
- 0.0000.00%
收盘价 04/26 15:59 (美东)
- 55.000
- +0.080+0.15%
盘前 08:50 (美东)
383.83亿总市值53.32市盈率TTM
0.000最高价0.000最低价0股成交量0.000今开54.920昨收0.00成交额0.00%换手率53.32市盈率(静)6.99亿总股本58.31652周最高1.53市净率383.09亿流通值42.94152周最低0.62股息TTM6.98亿流通股67.276历史最高1.13%股息率TTM0.00%振幅19.372历史最低--平均价1股每手
盘前分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
暂无内容
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
Corteva, Inc.（纽约证券交易所代码：CTVA）的交易折扣为47％吗？
关键见解根据两阶段股权自由现金流，Corteva的公允价值估计为104美元，Corteva的股价为54.92美元，这表明其估值可能低估了47％，分析师对CTV的目标股价可能被低估了47％
快讯 | 纽约证券交易所订单不平衡买入方有66036.0股股票
快讯 | Corteva Inc：宣布其董事会已批准普通股股息为每股0.16美分
新闻稿：Corteva宣布季度分红
Corteva 宣布季度分红美通社印第安纳波利斯，2024 年 4 月 26 日，印第安纳波利斯，2024 年 4 月 26 日 /PRNewswire/ — Corteva, Inc.（纽约证券交易所代码：CTVA）今天宣布其董事会已授权其股息
Corteva, Inc.（CTVA）预计将超过收益预期：该股能否走高？
UPL CORP 宣布完成对 CORTEVA 个人 MANCOZEB 业务的收购
全面和可持续农业解决方案的全球提供商UPL有限公司（UPL Corp）宣布已完成...
评论
专栏Today's Morning Movers and Top Ratings: JPM, C, WFC, GTLB and More
Morning Movers
Gapping up
$花旗集团(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$贝莱德(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
Gapping up
$花旗集团(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$贝莱德(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
26
1
Corteva's rising ROCE and efficient capital use are promising, but growing current liabilities may pose new risks. Despite this, the stock has given a decent 23% return over the past three years, indicating these developments are gaining deserved attention.
1
Corteva's high P/E ratio is sustained by its projected growth surpassing the broader market. Shareholders are at ease with the P/E, confident in the company's future earnings. The share price isn't anticipated to drop significantly soon under these conditions.
The CEO of Lavie Bio, Amit Noam, expressed satisfaction at achieving this milestone with Corteva, stating that the agreement showcases Lavie Bio's technological capabilities and enables the swift introduction of groundbreaking ag-biological solutions.
Corteva's guidance dispels concerns of lower earnings due to falling crop prices. Aptiv's 2024 forecast predicts a 7% sales growth despite stagnant global auto production. TD Cowen analyst Gautam Khanna deems Trane's results as 'good enough', rating the stock as Buy with a $235 price target.
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Peanny : Based on Lies…. The truth is on its way.